Clinical Trial Update: Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing chlorproguanil/dapsone with chloroquine and sulfadoxine-pyrimethamine for Plasmodium vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Chloroquine (chloroquine)
• Chlorproguanil-dapsone (Chlorproguanil-dapsone)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Vivax Malaria | Phase 3 | Status: COMPLETED